The scope of false, exaggerated and medical efficacy claims used for cosmetics in Taiwan is clarified.
On Jan. 10 and Jan. 19, 2019, TFDA released 2 cosmetic regulation drafts, “Particulars of Specific Purpose Cosmetics that May Be Voluntarily Modified” and “Regulations Governing of Criteria for the Label, Promotion and Advertisement of Cosmetic Products Identify False, Exaggerated or Medical Efficacy”. Cosmetic stakeholders with any suggestions or comments can send to us (cosmetic@chemlinked.com) before Mar 5, 2019. We will sort your suggestion, submit them to TFDA and send back the reply to you.
Cosmetic Hygiene Safety Administration Act released on May 2, 2018, stipulated that the labels, claims and advertisements of cosmetics shall not be false, exaggerated or indicate medical efficacy. The draft clarifies the scope of false, exaggerated or medical efficacy claims, as well as acceptable claims/labels/advertisements.
Special Webinar: Thursday, 27 March 2025 at 3 p.m. Cosmetic active ingredients and products are…
Editor Tim Probert caught up with four participants - Anne Charpentier, CEO of Skinobs; Mike…
Mieke Meintjes 27 February 2025 Scientists at Florida International University and the University of Miami,…